Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halfmann

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USAGage K Moreno, Katarina M Braun, Kasen K Riemersma, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Nature Communications|November 4, 2020
Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spreadGage K Moreno, Katarina M Braun, Kasen K Riemersma, et al.
The Journal of Clinical Investigation|March 2, 2023
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariantsSiriruk Changrob, Peter J Halfmann, Hejun Liu, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Nature Communications|February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membraneKathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Cell Host & Microbe|August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola VirusBronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Research Square|September 30, 2020
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2Christopher T Stamper, Haley L Dugan, Lei Li, et al.
BMC Bioinformatics|May 30, 2021
Hypergraph models of biological networks to identify genes critical to pathogenic viral responseSong Feng, Emily Heath, Brett Jefferson, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Distinct patterns of SARS-CoV-2 transmission in two nearby communities in Wisconsin, USAGage K Moreno, Katarina M Braun, Kasen K Riemersma, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Nature Communications|November 4, 2020
Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spreadGage K Moreno, Katarina M Braun, Kasen K Riemersma, et al.
The Journal of Clinical Investigation|March 2, 2023
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariantsSiriruk Changrob, Peter J Halfmann, Hejun Liu, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Nature Communications|February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membraneKathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Cell Host & Microbe|August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola VirusBronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Research Square|September 30, 2020
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2Christopher T Stamper, Haley L Dugan, Lei Li, et al.
BMC Bioinformatics|May 30, 2021
Hypergraph models of biological networks to identify genes critical to pathogenic viral responseSong Feng, Emily Heath, Brett Jefferson, et al.
Pageof 12